As of Feb 20, 2025, Chemed Corporation's Discounted Cash Flow (DCF) valuation estimates its share price at $468.8. This suggests it may be overvalued by (14.9%) compared to its current price of around $550.6, using a WACC of 7.6% and growth rates of 3.0%.
As of Feb 20, 2025, Chemed Corporation's Weighted Average Cost of Capital (WACC) is approximately 7.6%.
As of Feb 20, 2025, Chemed Corporation's Enterprise Value (EV) is approximately $6,950.0M. This value reflects the company's total market capitalization plus debt, minus cash and cash equivalents, providing a comprehensive measure of its overall value in the market.